Pharmaceuticals Content / Pharmaceuticals Content for 51³Ô¹ÏºÚÁÏ Davis en Receptor Location Matters for Psychedelic Drug Effects /health/news/receptor-location-matters-psychedelic-drug-effects A new study reveals receptor location impacts psychedelic drug effects. Learn how 51³Ô¹ÏºÚÁÏ Davis researchers are exploring implications for mental health treatment. February 16, 2023 - 11:00am Andy Fell /health/news/receptor-location-matters-psychedelic-drug-effects Plant Product Shows Promise in Mouse Model of Parkinson’s Disease /blog/plant-product-shows-promise-mouse-model-parkinsons-disease <p><span><span><span><span><span><span><span><span>A natural product from the dried root of a pea-family plant, potentially combined with an enzyme inhibitor discovered in the laboratory of Professor Bruce Hammock at the University of California, Davis, may provide hope in alleviating neuroinflammation in Parkinson’s disease, a team of researchers from Dalian Medical University, China, and 51³Ô¹ÏºÚÁÏ Davis announced Feb 21 in <a href="https://www.pnas.org/content/119/9/e2118818119"><em>Proceedings of the National</em> of </a><em><a href="https://www.pnas.org/content/119/9/e2118818119">Academy of Scien</a></em></span></span></span></span></span></span></span></span></p> February 18, 2022 - 3:40pm Andy Fell /blog/plant-product-shows-promise-mouse-model-parkinsons-disease Synthetic Version of CBD Treats Seizures in Rats /news/synthetic-version-cbd-treats-seizures-rats <p>A synthetic, non-intoxicating analogue of cannabidiol (CBD) is effective in treating seizures in rats, according to research by chemists at the University of California, Davis. The synthetic CBD alternative is easier to purify than a plant extract, eliminates the need to use agricultural land for hemp cultivation, and could avoid legal complications with cannabis-related products. The work was recently published in the journal&nbsp;<em><a href="https://rdcu.be/bEH8b">Scientific Reports</a></em>.&nbsp;</p> May 28, 2019 - 8:52am Andy Fell /news/synthetic-version-cbd-treats-seizures-rats